{"text": ["AbbVie's", "Imbruvica", "Approved", "for", "Type", "of", "Non-Hodgkin", "Lymphoma"], "created_at": "2018-08-27 22:03:42"}
{"text": ["AbbVie's", "Rare", "Blood", "Cancer", "Drug", "Combo", "Snags", "FDA", "Approval"], "created_at": "2018-08-27 13:38:49"}
{"text": ["We", "Did", "The", "Math", "FTXH", "Can", "Go", "To", "$26"], "created_at": "2018-08-27 12:54:47"}
{"text": ["We", "Did", "The", "Math", "FTXH", "Can", "Go", "To", "$26"], "created_at": "2018-08-27 12:54:47"}
{"text": ["Benzinga", "Pro's", "5", "Stocks", "To", "Watch", "Today"], "created_at": "2018-08-27 12:47:22"}
{"text": ["Today's", "Research", "Reports", "on", "Trending", "Tickers:", "AbbVie", "and", "Merck", "&", "Co."], "created_at": "2018-08-27 12:00:00"}
{"text": ["AbbVie", "Announces", "IMBRUVICA\u00ae", "(ibrutinib)", "Plus", "Rituximab", "Approval", "by", "U.S.", "FDA", "as", "First", "Chemotherapy-Free", "Combination", "Treatment", "in", "Adults", "with", "Waldenstr\u00f6m's", "Macroglobulinemia,", "a", "Rare", "Type", "of", "Blood", "Cancer"], "created_at": "2018-08-27 11:00:00"}
{"text": ["AbbVie", "(ABBV)", "Up", "3.7%", "Since", "Last", "Earnings", "Report:", "Can", "It", "Continue?"], "created_at": "2018-08-27 09:53:53"}
{"text": ["AbbVie", "(ABBV)", "Up", "3.7%", "Since", "Last", "Earnings", "Report:", "Can", "It", "Continue?"], "created_at": "2018-08-27 09:53:53"}
